Bank of Montreal

Bank of Montreal’s Syneron Medical Ltd ELOS Stock Holding History

Bank of Montreal’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2	Closed	–	–	4308
2016 Q2	$0	Buy	+2	New	+$14	﹤0.01%	4506

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Bank of Montreal's ELOS Position: Q3 2016 in Review

Bank of Montreal sold out of Syneron Medical Ltd (ELOS) in Q3 2016, closing a stake of 2 shares.

Bank of Montreal first reported a position in ELOS in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 65 funds tracked by Wall St. Rank hold ELOS as of Q3 2016.

Bank of Montreal reported no remaining Syneron Medical Ltd position as of Q3 2016 after selling out during the quarter.
Bank of Montreal sold 2 Syneron Medical Ltd shares in Q3 2016.
Bank of Montreal first reported a position in Syneron Medical Ltd in Q2 2016 and held it in 1 quarter.
Bank of Montreal's Syneron Medical Ltd position peaked at $0 in Q2 2016.
65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2016.

Based on Bank of Montreal's 13F filing for Q3 2016, filed 19 Oct 2016.